Lisata Therapeutics (LSTA)

• Market cap: $29.7M
• 1 day: -0.92%
• 5 days: 3.86%
• 1 month: -35.4%
• 3 months: -29.01%
• 6 months: 56.8%
• Year to date: 64.8%
• 1 year: 40.43%
• 5 years: -85.83%
• 10 years: -96.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Employees: 21